Who
In numbers
- Trades disclosed
- 87
- Buys
- 0
- Sells
- 9
- Bought
- $0
- Sold
- $7.1M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 Jul 2020
- Last trade
- 6 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 7 Aug 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code M | $350K1,970 at $177.46 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Sold | $792K1,970 at $402.16 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code M | $177K1,000 at $177.31 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN Amgenoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,970 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN Amgenoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,000 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Sold | $402K1,000 at $402.16 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN Amgenoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,970 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN Amgenoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,000 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code M | $350K1,970 at $177.46 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Sold | $792K1,970 at $402.16 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code M | $177K1,000 at $177.31 | filing |
| 6 Aug 2026filed 7 Aug 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Sold | $402K1,000 at $402.16 | filing |
| 7 May 2026filed 11 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code F | $29K88 at $331.11 | filing |
| 7 May 2026filed 11 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code F | $29K88 at $331.11 | filing |
| 6 May 2026filed 7 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code F | $25K76 at $329.59 | filing |
| 6 May 2026filed 7 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code F | $25K76 at $329.59 | filing |
| 5 May 2026filed 7 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —485 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | AMGN Amgenoption or derivative · Biotechnology | SEC FORM 4 Code A | $1.0M3,167 at $329.59 | filing |
| 5 May 2026filed 7 May 2026 | AMGN Amgenoption or derivative · Biotechnology | SEC FORM 4 Code A | $1.0M3,167 at $329.59 | filing |
| 5 May 2026filed 7 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —485 at $0.00 | filing |
News
Amgen (AMGN) Sales Grew 10%, but Can Earnings Catch Up to the Price?AMGN · insidermonkey.com · 21 Oct 2026Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?AMGN · fool.com · 20 Oct 2026AMGEN TO PRESENT AT THE EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS 2026AMGN · prnewswire.com · 20 Oct 2026
0 headlines in the last 90 days name Nancy A. Grygiel; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.